Valuation: BillionToOne, Inc.

Market Cap 5.3B 4.76B 4.35B 3.97B 7.48B 499B 7.71B 52.4B 20.89B 266B 19.91B 19.48B 840B P/E 2026 *
145x
P/E 2027 * 112x
Enterprise Value 5.78B 5.18B 4.74B 4.32B 8.14B 543B 8.4B 57.08B 22.76B 290B 21.68B 21.22B 915B EV / Sales 2026 *
12.7x
EV / Sales 2027 * 10.3x
Free-Float
74.57%
Yield 2026 *
-
Yield 2027 * -
1 day-1.26%
1 week-1.67%
Current month-1.67%
1 month+11.50%
3 months+21.58%
6 months+36.89%
Current year+36.16%
1 week 100.15
Extreme 100.15
114.91
1 month 90.48
Extreme 90.48
119.2
Current year 61.96
Extreme 61.96
150.44
1 year 61.96
Extreme 61.96
150.44
3 years 61.96
Extreme 61.96
150.44
5 years 61.96
Extreme 61.96
150.44
10 years 61.96
Extreme 61.96
150.44
Manager TitleAgeSince
Chief Executive Officer 37 01/01/2016
President 36 01/01/2016
Director of Finance/CFO 62 01/01/2024
Director TitleAgeSince
Chairman 37 01/01/2016
Director/Board Member 36 01/01/2016
Director/Board Member 62 01/03/2019
Date Insider Type Main position Quantity % Market Cap. Importance
15/10/26 Exercice

Chief Executive Officer

15,450 0.0362%
12/10/26 Exercice

Chief Executive Officer

52,668 0.1235%
8/10/26 Exercice

Compliance Officer

16,000 0.0375%
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%-1.67% - - 5.3B
-4.83%+2.88%+55.87%+69.12% 69.4B
+0.02%+1.07%+10.63%+76.66% 57.24B
-1.34%+2.98%+24.79%+100.18% 57.62B
+2.84%+1.89%+29.17%+37.28% 43.65B
+5.43%+10.16%+22.75%+107.99% 44.03B
+8.39%+0.28%+212.55%+790.65% 38.08B
-1.86%+11.46%+26.67%+61.40% 36.31B
-2.97%-9.84%+88.86%+76.17% 32.61B
-2.18%+5.68%+36.21%-0.69% 25.47B
Average +0.18%+1.80%+56.39%+146.53% 40.97B
Weighted average by Cap. +0.07%+2.38%+52.10%+138.82%

Financials

2026 *2027 *
Net sales 455M 408M 373M 340M 641M 42.75B 661M 4.49B 1.79B 22.81B 1.71B 1.67B 72.01B 574M 515M 470M 429M 809M 53.94B 834M 5.67B 2.26B 28.78B 2.15B 2.11B 90.85B
Net income 42.86M 38.44M 35.13M 32.07M 60.42M 4.03B 62.32M 423M 169M 2.15B 161M 157M 6.79B 59.89M 53.72M 49.09M 44.82M 84.44M 5.63B 87.1M 592M 236M 3B 225M 220M 9.48B
Net Debt 474M 425M 388M 354M 668M 44.52B 689M 4.68B 1.87B 23.76B 1.78B 1.74B 74.99B 604M 541M 495M 452M 851M 56.74B 878M 5.96B 2.38B 30.27B 2.27B 2.22B 95.57B
Projected Income Statement - Annual - BillionToOne, Inc.
Logo BillionToOne, Inc.
BillionToOne, Inc. is a precision diagnostics company that quantifies biology to create molecular diagnostics. The Company's proprietary molecular counting platform is designed to detect and measure deoxyribonucleic acid (DNA) molecules at a single-count level to help improve disease detection. It applies the proprietary technology to non-invasive prenatal screening (Prenatal) and liquid biopsy (Oncology). Its Quantitative Counting Templates (QCTs), power its ability to detect and measure tiny and sparse disease-related DNA fragments, or molecules, at the single base-pair level. These include pregnancy-related DNA that code for recessively inherited conditions such as sickle cell disease and cystic fibrosis and ctDNA in the case of cancer. Its prenatal products include UNITY Complete, UNITY Fetal Risk Screen, UNITY Aneuploidy Screen, UNITY Fetal RhD NIPT, UNITY Fetal Antigen NIPT, and UNITY Fetal Antigen CTA NIPT. Its oncology products include Northstar and Northstar Select.
Employees
713
Date Price Change Volume
07/11/26 US$111.39 -0.89% 353,725
05/11/26 US$112.39 -1.32% 1,684,978
04/11/26 US$113.89 +3.11% 582,226
03/11/26 US$110.45 +0.04% 360,372
02/11/26 US$110.41 -2.57% 635,919
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BillionToOne, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
112.39USD
Average target price
129.00USD
Spread / Average Target
+14.78%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BillionToOne, Inc.
  1. Stock Market
  2. Stocks
  3. BLLN Stock